-1 ntri
Nutrisystem beats handily; guides Q2 and Y06 way above consensus (NTRI) 50.70 +0.20: Reports Q1 (Mar) earnings of $0.60 per share, $0.17 better than the Reuters Estimates consensus of $0.43; revenues rose 292.1% year/year to $146.8 mln vs the $125.4 mln consensus. Co added ~235,000 Direct channel new customers, a 267%y/y; co expects Q2 EPS of $0.44-0.46, including stock based compensation, Reuters consensus is $0.34, see revenues in the range of $118-122 mln, consensus is $103.9 mln; co expects Y06 EPS in the range of $1.80-1.90, ex stock based compensation, Reuters compsensation is $1.37, expecte revs between $490-510 mln, consensus is $426 mln
2-IMCL
Imclone reports above consensus (IMCL) 36.43 : Reports Q1 (Mar) earnings of $1.43 per share, $0.28 better than the Reuters Estimates consensus of $1.15; revenues rose 185.8% year/year to $245.1 mln vs the $237 mln consensus. Co reported royalty revs of $60.3 mln compared with $36.4 mln a year ago. Royalty revenue for Q1 of 2006 includes $53.8 mln, representing 39% of Bristol-Myers Squibb's in-market ERBITUX net sales of $138.0 mln, compared with Q1 of 2005 in-market net sales of $87.1 mln
3- LCAV
LCA Vision reports $0.12 above consensus; raises Y06 guidance (LCAV) 51.20 : Reports Q1 (Mar) earnings of $0.61 per share, $0.12 better than the Reuters Estimates consensus of $0.49; revenues rose 46.2% year/year to $73.4 mln vs the $67.4 mln consensus. Co raises guidance for FY06, sees EPS of $1.75-1.85, up from previous guidance of $1.65-1.75, vs. $1.73 consensus.
4-WIBC
WILL BE ADDED TO S&P 600 ON 28TH
Nutrisystem beats handily; guides Q2 and Y06 way above consensus (NTRI) 50.70 +0.20: Reports Q1 (Mar) earnings of $0.60 per share, $0.17 better than the Reuters Estimates consensus of $0.43; revenues rose 292.1% year/year to $146.8 mln vs the $125.4 mln consensus. Co added ~235,000 Direct channel new customers, a 267%y/y; co expects Q2 EPS of $0.44-0.46, including stock based compensation, Reuters consensus is $0.34, see revenues in the range of $118-122 mln, consensus is $103.9 mln; co expects Y06 EPS in the range of $1.80-1.90, ex stock based compensation, Reuters compsensation is $1.37, expecte revs between $490-510 mln, consensus is $426 mln
2-IMCL
Imclone reports above consensus (IMCL) 36.43 : Reports Q1 (Mar) earnings of $1.43 per share, $0.28 better than the Reuters Estimates consensus of $1.15; revenues rose 185.8% year/year to $245.1 mln vs the $237 mln consensus. Co reported royalty revs of $60.3 mln compared with $36.4 mln a year ago. Royalty revenue for Q1 of 2006 includes $53.8 mln, representing 39% of Bristol-Myers Squibb's in-market ERBITUX net sales of $138.0 mln, compared with Q1 of 2005 in-market net sales of $87.1 mln
3- LCAV
LCA Vision reports $0.12 above consensus; raises Y06 guidance (LCAV) 51.20 : Reports Q1 (Mar) earnings of $0.61 per share, $0.12 better than the Reuters Estimates consensus of $0.49; revenues rose 46.2% year/year to $73.4 mln vs the $67.4 mln consensus. Co raises guidance for FY06, sees EPS of $1.75-1.85, up from previous guidance of $1.65-1.75, vs. $1.73 consensus.
4-WIBC
WILL BE ADDED TO S&P 600 ON 28TH